Diabetes drug maker sues over compounded versions of Mounjaro
Sep 20, 2023
The lawsuits are meant to stop the other companies from “the unlawful marketing and sale of non-FDA approved compounded products.”
Senate hearing, OIG report target substance use disorders
By
Kimberly Marselas
Feb 01, 2024
Both reveal that older adults need more help than ever when it comes to getting the treatment they need to address such issues.
Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.
US medical drug shortages reach record high
Apr 15, 2024
Americans are facing more shortages of the drugs they need for medical care than ever before, a national pharmacy database shows.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.